loader image

Clinical Operations

Our team leverages their industry experience, extensive therapeutic knowledge, and a dedication to helping clients improve lives. We provide efficient study start up, quick enrollment, and quality execution.

Biostatistics & Statistical Programming

All PharPoint biostatisticians have advanced degrees. Our wide range of services include study design, DMC support, and in-house custom programming.

Data Management

Our in-house team is committed to providing you with on-time, on-budget delivery, with experience in over 18 EDC platforms. By performing data cleaning and reviews on a continuing basis during enrollment and study conduct, our team can lock a database with 5 days of last patient last visit.

Strategic Consulting

The cornerstone of PharPoint Research is our strategic consulting expertise, which is based on our consultants’ involvement in multiple successful development programs. We actively listen to our sponsors and take their challenges seriously.

PharPoint's repeat business rate
+ studies
Participated in since 2006
Our leadership team's average industry experience
Regulatory submissions

Recent Accolades

Resources & Insights

Evolving regulations and virtual trials
Clinical Operations
PharPoint's Clinical Operations Director on COVID-19 and Virtual Trials As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas. PharPoint is a strong advocate of this approach as an option to incorporate efficiencies for select...
COVID-19: Update from PharPoint Research
Press Release
COVID-19: Update from PharPoint Research As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health. Our leadership team has been closely monitoring the situation since the...
Rare Disease Day 2020
Industry News

This February 29th, PharPoint acknowledges Rare Disease Day. We are relentless in supporting clients so that they may advance rare disease research and the approval of breakthrough treatments.

Speak with an expert